Ultrasound and multi-biomarker disease activity score for assessing and predicting clinical response to tofacitinib treatment in patients with rheumatoid arthritis

Abstract Background Musculoskeletal ultrasound (MSUS) and the multi-biomarker disease activity (MBDA) score are outcome measures that may aid in the management of rheumatoid arthritis (RA) patients. This study evaluated tofacitinib response by MSUS/MBDA scores and assessed whether baseline MSUS/MBDA...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Amir A. Razmjou, Jenny Brook, David Elashoff, Gurjit Kaeley, Soo Choi, Tanaz Kermani, Veena K. Ranganath
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BMC 2020-10-01
श्रृंखला:BMC Rheumatology
विषय:
Rheumatoid arthritis
Ultrasound
Outcome measures
Multi-biomarker disease activity score
ऑनलाइन पहुंच:http://link.springer.com/article/10.1186/s41927-020-00153-4
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन